116
Participants
Start Date
April 15, 2013
Primary Completion Date
June 16, 2017
Study Completion Date
June 16, 2017
Tigecycline (Tygacil)
Tigecycline 50 mg intravenously. Therapy conducted according to Japanese LPD of Tygacil. Tygacil will be dosed according to labeling. The administration and duration of the therapy will be determined by the treating physician to meet the patient individual needs for treatment.
Lead Sponsor
Pfizer
INDUSTRY